The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Residual disease after HER2-directed therapies in the neosphere study: Modulation of tumor lymphocyte infiltration (TIL) and prognosis.
 
Giampaolo Bianchini
Honoraria - Eisai; Genomic Health; Roche/Genentech
Consulting or Advisory Role - Celgene; Eisai; Genomic Health
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche
 
Tadeusz Pienkowski
No Relationships to Disclose
 
Young-Hyuck Im
No Relationships to Disclose
 
Giulia Valeria Bianchi
No Relationships to Disclose
 
Ling-Ming Tseng
No Relationships to Disclose
 
Mei-Ching Liu
Consulting or Advisory Role - Pfizer; Roche
 
Ana Lluch
Speakers' Bureau - Novartis; Pfizer; Roche
 
Vladimir Semiglazov
No Relationships to Disclose
 
Juan de la Haba-Rodriguez
No Relationships to Disclose
 
Do-Youn Oh
Consulting or Advisory Role - AstraZeneca; Baxalta; Lilly; Merck; Novartis
 
Brigitte Poirier
No Relationships to Disclose
 
Jose Luiz Pedrini
No Relationships to Disclose
 
Pinuccia Valagussa
No Relationships to Disclose
 
Luca Gianni
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genomic Health; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Synaffix; Synthon; Taiho Pharmaceutical; Tiziana Life Sciences
Patents, Royalties, Other Intellectual Property - Roche